GLANZMANN THROMBASTHENIA

Clinical trials for GLANZMANN THROMBASTHENIA explained in plain language.

Never miss a new study

Get alerted when new GLANZMANN THROMBASTHENIA trials appear

Sign up with your email to follow new studies for GLANZMANN THROMBASTHENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New drug trial aims to stop dangerous bleeding in rare blood disorder

Disease control Ongoing

This early-stage clinical trial is testing a new drug called HMB-001 in adults with Glanzmann thrombasthenia, a rare inherited bleeding disorder. The main goals are to find a safe dose and see if regular injections can prevent or reduce the number and severity of bleeding episode…

Matched conditions: GLANZMANN THROMBASTHENIA

Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

GLANZMANN THROMBASTHENIA

Get alerted when new GLANZMANN THROMBASTHENIA trials appear

New drug trial aims to stop dangerous bleeding in rare blood disorder